The first patient has been dosed in a Phase 2 clinical trial testing RAG-17 in people with ALS who carry mutations in the ...

QRL-101, an oral small molecule being developed by QurAlis, was safe and reduced nerve-cell overactivity in ALS patients in ...

NRG Therapeutics Ltd. (“NRG”), a clinical stage neuroscience company targeting a novel mechanism to rectify mitochondrial ...

NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...

China dominates and weaponises rare earth supply chain. India’s EV ecosystem can be insulated from it through carefully ...

As the world’s largest technology and automotive companies gathered in Las Vegas this week for the 2026 Consumer Electronics Show (CES), China’s Great Wall Motors (GWM) arrived with a message that ...

The study introduces a novel "multi-route" administration protocol for Wharton’s Jelly-derived Mesenchymal Stem Cells (WJ-MSCs). Unlike previous trials that relied on a single delivery method, this ...

ISRO's PSLV missions faced back-to-back failures in the third stage, but the overall track record remains strong despite ...

Late last year, we drove BMW’s new iX3. It’s the first of a series of electric BMWs to use a newly developed platform, known ...

Honda’s H badge is changing, and it’s not just for EVs. The new symbol now represents Honda’s entire car business.

Even if you have a pretty good idea of what it would take to turn a classic car into a Leaf-powered EV, it's still fun to ...

If you’ve spent enough time riding electric bikes, you quickly realize that power is only part of the draw. Another big part ...